The purpose of this study was to analyze inter-and intra-fractional changes in tumor volume with respect to both spatial and volumetric parameters among patients treated by SBRT for lung cancer. Twelve patients (13 tumors) were treated by SBRT with abdominal compression in 3-5 fractions over a 2 week period to a median dose of 60 Gy (range, 48 to 60 Gy).
Introduction
Stereotactic body radiotherapy (SBRT) has emerged as an exciting means of delivering high doses of radiotherapy with excellent reported local control rates for both primary and oligometastatic malignancies (1) (2) (3) (4) . SBRT, which is critically dependent on the accurate delineation and localization of the tumor volume, has become feasible through major technological advancements including improved imaging, treatment planning software, and radiation therapy delivery systems. In aggregate, these advances have allowed for the reduction of planning target volume (PTV) margins, improved dosimetric coverage of the tumor, decreased dose Technology in Cancer Research & Treatment, Volume 10, Number 5, October 2011 to surrounding normal tissue, and steep dose gradients, which have all contributed to effective dose escalation.
Classically, SBRT was delivered with dependence on an external fiducial system for target localization (5) but has been supplanted by image guided radiation therapy (IGRT). When utilizing IGRT, residual margins of only a few millimeters are obtainable after correction from bony and soft tissue registry (6, 7) . Tumor motion, however, remains a substantial problem for lung cancers as tumors have been shown to move up to 35 mm with normal respiration (8) . Studies analyzing the role of motion management therefore remain critical to maintaining the high therapeutic ratio of SBRT. Visual assessment of near real-time 3-D alignment of the tumor with respect to planning images has been proposed to be critical for accurate delivery of radiotherapy (9). IGRT allows for tracking of both spatial and volumetric changes over the course of SBRT. The present study evaluated the inter-and intra-fractional Table adjustments and volumetric response of thirteen lung tumors treated by SBRT to assess the utility of image guided SBRT.
Methods
This study was reviewed and approved by our institutional review board.
Patients
Between May 2007 and October 2009, 12 patients with a total of 13 stage I non-small cell lung cancers (NSCLCs) were treated by SBRT on an Elekta Synergy S linear accelerator (Elekta, Stockholm, Sweden). Twelve tumors were defined as "peripheral," positioned at least 2 cm outside of the proximal bronchial tree. One tumor was defined as a central lesion and was found to abut the mediastinum. Three patients were treated to a total dose of 48 Gyin 4 fractions. Nine patients were treated to a total dose of 60 Gyin 3 fractions. The patient with a centrally located lesion was treated to a total dose of 40 Gyin 5 fractions. Tumors 11 and 12 were treated within the same patient. A retrospective analysis was performed on all planning CT scans and CBCT images. Tumor and treatment characteristics are described in Table I .
Treatment Preparation
Prior to delivery of SBRT, all patients underwent a setup procedure at the Elekta Synergy S linear accelerator with supine placement in a stereotactic body frame (Elekta, Stockholm, Sweden) and abdominal compression system. 2D real time, fluoroscopic imaging was then taken for each treated tumor to ensure a diaphragmatic excursion of less than 1 cm. Treatment planning images were then acquired utilizing 3-mm slice free breathing CT scanning. All CT data sets were then transferred to a Pinnacle treatment planning workstation (Phillips, Andover, MA). The target lesion was then delineated and designated as the gross tumor volume (GTV) on all axial CT slices using standardized CT lung window settings. An additional 0.5 cm in the axial plane and 0.9 to 1.2 cm in the longitudinal plane (cranial-caudal) were added to account for microscopic extension and respiratory motion and constituted the PTV.
IGRT and Treatment Execution
Prior to the clinical delivery of each SBRT fraction, the patient was aligned with the isocenter based on fixed 3D coordinates defined during simulation. After abdominal compression was placed to a level determined during treatment planning, 55 kV CBCT images were then acquired to include the GTV. Each treatment course included the acquisition of 3 to 6 CBCT scans. All patients had CBCTs taken prior to the delivery of each SBRT fraction. There were 11 fractions of SBRT treatment delivered in which CBCTs were taken intra-fractionally, midway through treatment after approximately half of the scheduled beams were delivered. Each CBCT scan was then registered to treatment planning images using grey value parameters (lung windowing) on Elekta X-ray volumetric imaging (XVI) software. CBCT images were then visually inspected by the treating radiation oncologist in 3 orthogonal axes (axial, sagital, and coronal). Then CBCT tumor was manually registered to CT simulation tumor and additional shifts were performed by the radiation therapist if deemed necessary. Translational Table shifts were performed in x-lateral (right-left), y-longitudinal (superior-inferior), and z-vertical (anterior-posterior) directions and recorded. No rotational adjustments were made in yaw, pitch, or roll. All 12 patients successfully completed 13 SBRT treatment courses without incident over the course of 2-3 weeks with typically 4-5 days between successive fractions.
Analysis of Geometric and Volumetric Trends
To evaluate for inter-and intra-fractional positional changes in tumor location, all recorded Table shifts were processed into shift vectors by taking the root sum of the squares (vector 5 √ x 2 1 y 2 1 z 2 ). Means and standard deviations were calculated.
To assess for inter-fractional volumetric change, all CBCT data sets were unarchived and imported into Pinnacle software. To minimize bias and interobserver variability a single non-treating radiation oncologist contoured visible gross tumor on all axial slices for each CBCT utilizing standard CT lung windows. Baseline planning CT scans and GTVs were used for reference. Volumes were calculated by the Pinnacle software three-dimensional volume-rendering program.
Results

Analysis of Inter-fractional Alignment
Inter-fraction directional Table shifts applied for all SBRT fractions delivered across all tumors are outlined in Table II . The maximum absolute shifts found in the lateral, longitudinal, and vertical directions were 10.0, 231.0, and 212.0 mm, respectively. Scatterplots of directional shifts are shown in Figure 1 . Of all SBRT fractions delivered, 3/44 (6.8%), 13/44 (29.5%), and 3/44 (6.8%) had shifts of 5 mm in the lateral, longitudinal, and vertical directions, respectively. Shifts of 10 mm were applied 1/44 (2.3%), 6/44 (13.6%), and 1/44 (2.3%) of times in the lateral, longitudinal, and vertical directions, respectively. Shifts of 20 mm or more were applied only in the longitudinal direction but constituted 5/44 (11.4%) of those made in that direction. The mean inter-fraction directional Table shifts found across all fractions delivered in the lateral, longitudinal, and vertical directions were 0.4, 24.8, and 21.5 mm, respectively. Table III summarizes means 6 standard deviations (SDs) of inter-fraction directional shift data. There were no clear temporal trends noted.
Inter-fractional 3D shift vector magnitudes were computed by taking the root sum squares of directional shift components (vector 5 √ x 2 1 y 2 1 z 2 ). 
Analysis of Intra-fractional Alignment
Of all 44 SBRT fractions that were delivered, 11 were interrupted midway through the fraction, and a CBCT was repeated to assess gross tumor alignment. Additional Table shifts were made utilizing the same process as described above. Table  shifts were then recorded as measurements relative to couch position at the start of the respective fraction. All 3 of 3 fractions of tumors 7 and 8, the first 2 of 3 fractions of tumor 9, the third of 3 fractions of tumor 10, the first of 3 fractions of tumor 12, and the first of 5 fractions of tumor 13 were evaluated by intra-fractional CBCT assessment.
Intra-fractional directional Table shifts applied are shown in Table V . Directional shifts ranged from 0-5.0 mm. Only 1/33 (3.0%) of total intra-fractional shifts applied was 5 mm and observed for tumor 10, fraction 3 in the vertical direction. The mean 6 SD over all intra-fractional directional shifts was 20.12 6 1.8 mm.
Intra-fractional 3D shift vector magnitudes were computed by taking the root sum squares of directional shift components (vector 5 √ x 2 1 y 2 1 z 2 ). Figure 3 . Of 11 shift vectors, only 1/11 (9.1%) were 5 mm. The overall mean and SD of all intra-fractional shift vectors was 2.6 6 1.7 mm.
Analysis in Volumetric Changes of Gross Tumor Over Time
GTVs for each tumor per fraction are summarized in Table VII . Most tumors in our study (11/13) showed overall regression of GTV. 2 of 13 tumors exhibited increased volume at the last fraction with respect to baseline. The greatest percent change in GTV ranged from 38.6% increase in tumor 13 to 72.3% reduction in tumor 2. Figure 4 illustrates the absolute changes in GTV over the course of SBRT. Although the overall mean reduction in GTV was 21.1% for all tumors over the course of SBRT, absolute changes were usually very small (2 cc).
Discussion
SBRT relies on the critical principle of accurate targeting and rapid dose fall-off when delivering a single or few fractions of high dose radiation (10). This technique capitalizes on the radiobiological advantages of extreme hypofractionation and offers patients with lung cancers (1, 11, 12) and other malignancies (2-4), who are unsuitable for surgical resection an excellent alternative for palliation or cure. Several studies have shown that SBRT for early stage lung cancers result in local control rates comparable to historically reported surgical outcomes at greater than 90% (11, 12) . It is important to recognize, however, that the success of SBRT is critically dependent on target localization. normal tissue doses must be balanced with the avoidance of compromising target coverage and potential marginal misses (10).
According to the recommendations of the ICRU 50, an appropriate PTV margin must account for set-up error and should be utilized to ensure that all gross tumor and suspected microscopic disease, constituting the clinical target volume (CTV), is covered during treatment (17). In accordance with ICRU 62, an additional margin should be incorporated to account for internal motion from physiologic causes such as respiration (18). Defining the internal target volume (ITV) remains IGRT is of immense utility because it allows for both interand intra-fractional treatment verification and assessment of changes in tumor position, shape, and size (19). The advent of in-room CT scanners (20, 21) and CBCT, which utilizes tomographic reconstruction of a target from a series of two-dimensional radiographs taken during a single rotation around the patient (22), allow for visualization of the target at any point during the entire treatment course. Both of these modalities have vastly improved the ability to detect field placement errors over that of more traditional, poorer quality, 2D portal imaging (23).
The discrepancies in spatial alignment detected on pretreatment CBCT imaging are correctable with on-line imaging and appropriate Table shifts (24). Systematic and random errors occur with simulation to treatment and day-to-day set-up variations, respectively. Such errors can include misalignment of isocenter lasers to the stereotactic body frame or degree of abdominal compression and can be mitigated with pretreatment image guided target realignment, which has been well established for reducing normal tissue doses when treating tumors affected by breathing (25, 26). Continually improving imaging resolution will likely translate into clinically observable benefit as data begins to mature with longer patient follow-up (27). The importance of image guidance over stereotactic alignment has been evaluated by others who have treated patients without the use of a body frame with acceptable outcomes (28). Our study showed that image guidance with 55 kV CBCT prior to each delivered fraction allowed for real-time adjustment of significant interfractional shifts, particularly in the superior-inferior direction, that would have resulted in target misses if treatment were performed without IGRT verification. We did not find the same conclusion for intra-fractional motion.
Daily IGRT also allows for volumetric assessment of changes in size or shape of the tumor over the course of SBRT and should prompt consideration for adaptive planning (29). Tumor volume regression has been documented Table V Intra-fraction directional shifts in gross tumor with respect to couch position at start of fraction.
Tumor
Fraction on serial imaging during conventional fractionated external beam radiotherapy for lung cancers (30). One study utilizing electronic portal images reported a greater than 20% tumor volume shrinkage in over 40% of patients that were evaluated (31). Another study utilizing megavoltage CT images found a 60-80 % reduction in GTVs for treated lung cancer patients (32). This group also discovered that adaptive planning allowed for an average 21% reduction in ipsilateral lung volume receiving 20 Gy(32). In our study, we found that the mean overall reduction in GTV was 21.1 %, although absolute reductions in volume were usually small (2 cc) over course of SBRT. The implications with respect to adaptive planning to both improve target conformality and to decrease dose to surrounding normal lung tissue need to be explored further.
A major limitation of this study was the small number of assessable patients and tumors. For example, most of the marginal misses which would have occurred with the omission of image verification to stereotactic set-up would have occurred in three of four fractions for tumor 2 and three of three fractions in tumor 7, primarily in the superior-inferior directions. These errors were likely systematic as they were of similar magnitude in each fraction and in the same direction. If these two tumors were eliminated from this analysis, then only 3 out of a total of 37 fractions would have resulted in a marginal miss (twice in the vertical direction in tumor 8 and once in the lateral direction in tumor 11), with an average miss of only 3 mm. A larger cohort of patients would have likely reduced the observed benefit of image guided verification to stereotactic alignment, but would still likely have remained significant.
Another limitation of this study was that rotational changes were not corrected for during treatment nor analyzed. Others have shown that rotational errors during SBRT for spinal malignancies Abbreviations: GTV 5 gross tumor volume; cc 5 cubic centimeter; fx 5 fraction; sim 5 simulation scan volume. are often negligible with little impact on both PTV coverage or dose tolerance to the surrounding spinal cord, unless rotational errors were found to be greater than 2 degrees (33, 34). Rotational adjustments for lung cancers are likely unnecessary as irradiation to immediately surrounding lung parenchyma is much less critical to toxicity avoidance than is irradiation to the spinal cord during treatment of spinal malignancies.
Conclusion
Our study showed that inter-fraction IGRT is important to verifying stereotactic localization and accurate delivery of radiation during SBRT for lung malignancies. Significant inter-fractional Table shifts were applied, particularly in the superior-inferior direction, which would have exceeded the accepted PTV margins of 10 mm superior-inferior and 5 mm radially, leading to potential marginal misses had treatment been delivered under stereotactic guidance only. The observed relative GTV reduction of 21% may have implications for adaptive planning in the future. 
